Cellectis S.A. (CLLS)
Cellectis S.A. Statistics
Share Statistics
Cellectis S.A. has 100.29M shares outstanding. The number of shares has increased by 46.66% in one year.
| Shares Outstanding | 100.29M |
| Shares Change (YoY) | 46.66% |
| Shares Change (QoQ) | 66.03% |
| Owned by Institutions (%) | 12.75% |
| Shares Floating | 89.98M |
| Failed to Deliver (FTD) Shares | 1.05K |
| FTD / Avg. Volume | 0.3% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -4.43 and the forward PE ratio is -1.52. Cellectis S.A.'s PEG ratio is 0.06.
| PE Ratio | -4.43 |
| Forward PE | -1.52 |
| PS Ratio | 3.93 |
| Forward PS | 3.2 |
| PB Ratio | 1.24 |
| P/FCF Ratio | 8.51 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cellectis S.A..
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.7.
| Current Ratio | 1.73 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.7 |
| Debt / EBITDA | -5.77 |
| Debt / FCF | 4.78 |
| Interest Coverage | -7.99 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $192.16K |
| Profits Per Employee | $-170.19K |
| Employee Count | 216 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.45M |
| Effective Tax Rate | 14.92% |
Stock Price Statistics
The stock price has increased by -35.43% in the last 52 weeks. The beta is 3.38, so Cellectis S.A.'s price volatility has been higher than the market average.
| Beta | 3.38 |
| 52-Week Price Change | -35.43% |
| 50-Day Moving Average | 1.35 |
| 200-Day Moving Average | 1.79 |
| Relative Strength Index (RSI) | 70.85 |
| Average Volume (20 Days) | 346.21K |
Income Statement
In the last 12 months, Cellectis S.A. had revenue of 41.51M and earned -36.76M in profits. Earnings per share was -0.37.
| Revenue | 41.51M |
| Gross Profit | 21.63M |
| Operating Income | -59.55M |
| Net Income | -36.76M |
| EBITDA | -15.84M |
| EBIT | -29.31M |
| Earnings Per Share (EPS) | -0.37 |
Balance Sheet
The company has 143.25M in cash and 91.46M in debt, giving a net cash position of 51.79M.
| Cash & Cash Equivalents | 143.25M |
| Total Debt | 91.46M |
| Net Cash | 51.79M |
| Retained Earnings | -329.61M |
| Total Assets | 383.54M |
| Working Capital | 120.8M |
Cash Flow
In the last 12 months, operating cash flow was 22.99M and capital expenditures -3.84M, giving a free cash flow of 19.15M.
| Operating Cash Flow | 22.99M |
| Capital Expenditures | -3.84M |
| Free Cash Flow | 19.15M |
| FCF Per Share | 0.21 |
Margins
Gross margin is 52.12%, with operating and profit margins of -143.48% and -88.57%.
| Gross Margin | 52.12% |
| Operating Margin | -143.48% |
| Pretax Margin | -104.1% |
| Profit Margin | -88.57% |
| EBITDA Margin | -38.16% |
| EBIT Margin | -143.48% |
| FCF Margin | 46.13% |
Dividends & Yields
CLLS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CLLS is $6, which is 265.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 265.9% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.65 |
| Piotroski F-Score | 5 |